Conducting Psychosocial Intervention Research among Adolescents and Young Adults with Cancer: Lessons from the PRISM Randomized Clinical Trial

被引:8
|
作者
Rosenberg, Abby R. [1 ,2 ]
Junkins, Courtney C. [1 ]
Sherr, Nicole [1 ]
Scott, Samantha [1 ]
Klein, Victoria [3 ,4 ]
Barton, Krysta S. [1 ]
Yi-Frazier, Joyce P. [1 ]
机构
[1] Seattle Childrens Res Inst, Palliat Care & Resilience Lab, Seattle, WA 98101 USA
[2] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98105 USA
[3] Dana Farber Canc Inst, Dept Psychosocial Oncol & Palliat Care, Boston, MA 02101 USA
[4] Boston Childrens Hosp, Dept Pediat, Boston, MA 02101 USA
来源
CHILDREN-BASEL | 2019年 / 6卷 / 11期
基金
美国国家卫生研究院;
关键词
psychosocial; clinical trial; adolescent and young adult; cancer; palliative care; OF-LIFE; DECISION-MAKING; CARE; PARTICIPATION; PARENTS; RESILIENCE; ENROLLMENT; CHILDREN; STANDARDS; DIAGNOSIS;
D O I
10.3390/children6110117
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: Adolescents and young adults (AYAs) with cancer have poor psychosocial outcomes, in part because their limited participation in clinical trials precludes intervention-testing. We previously reported results of a successful randomized trial testing an AYA-targeted psychosocial intervention. Here, we aimed to describe strategies learned during the trial's conduct. Methods: We summarized data from the medical record and staff field notes regarding reasons for participation/non-participation. We conducted two focus groups with study staff; directed content analyses identified strategies for success. Results: 92 AYAs enrolled (77% of approached; n = 50 Usual Care (control), n = 49 PRISM (intervention)). In eligible families who declined participation (n = 22 AYAs, n = 8 parents), the AYAs more commonly had advanced cancer (n = 11 (37%) declined vs. n = 25 (26%) enrolled). AYA reasons for non-enrollment were predominantly "not interested"; parents worried participation was "too burdensome." Staff strategies for accrual included having significant time to introduce the study and underscoring a desire to learn from the patient. After enrollment, AYAs who discontinued participation were more commonly assigned to control (n = 5 (10%) control vs. n = 2 (4%) intervention). Only n = 1 AYA chose to discontinue participation after receiving the intervention. Conclusions: Efforts to engage AYAs prior to and during studies may help with accrual and retention.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Effects of a perioperative geriatric intervention for older adults with Cancer: A randomized clinical trial
    Nipp, Ryan D.
    Qian, Carolyn L.
    Knight, Helen P.
    Ferrone, Cristina R.
    Kunitake, Hiroko
    Fernandez-del Castillo, Carlos
    Lanuti, Michael
    Qadan, Motaz
    Ricciardi, Rocco
    Lillemoe, Keith D.
    Temel, Brandon
    Hashmi, Ardeshir Z.
    Scott, Erin
    Stevens, Erin
    Williams, Grant R.
    Fong, Zhi Ven
    O'Malley, Terrence A.
    Franco-Garcia, Esteban
    Horick, Nora K.
    Jackson, Vicki A.
    Greer, Joseph A.
    El-Jawahri, Areej
    Temel, Jennifer S.
    JOURNAL OF GERIATRIC ONCOLOGY, 2022, 13 (04) : 410 - 415
  • [22] Examining key sociodemographic characteristics of adolescents and young adults with cancer: A post hoc analysis of the Promoting Resilience in Stress Management randomized clinical trial
    Lau, Nancy
    Bradford, Miranda C.
    Steineck, Angela
    Scott, Samantha
    Bona, Kira
    Yi-Frazier, Joyce P.
    McCauley, Elizabeth
    Rosenberg, Abby R.
    PALLIATIVE MEDICINE, 2020, 34 (03) : 336 - 348
  • [23] Health professional perceptions of communicating with adolescents and young adults about bone cancer clinical trial participation
    Lavender, Verna
    Gibson, Faith
    Brownsdon, Alexandra
    Fern, Lorna
    Whelan, Jeremy
    Pearce, Susie
    SUPPORTIVE CARE IN CANCER, 2019, 27 (02) : 467 - 475
  • [24] A Randomized Controlled Trial of a Physical Activity Intervention for Self-management of Fatigue in Adolescents and Young Adults With Cancer
    Erickson, Jeanne M.
    Tokarek, Nathan
    Ke, Weiming
    Swartz, Ann
    CANCER NURSING, 2021, 44 (04) : 263 - 271
  • [25] Patterns of National Cancer Institute-Sponsored Clinical Trial Enrollment in Black Adolescents and Young Adults
    Roth, Michael
    Beauchemin, Melissa
    Kahn, Justine M.
    Bleyer, Archie
    CANCER MEDICINE, 2021, 10 (21): : 7620 - 7628
  • [26] Wonders & Worries: A randomized clinical trial of a psychosocial intervention for children who have a parent with cancer
    Phillips, Farya
    Prezio, Elizabeth A.
    Currin-McCulloch, Jennifer
    Jones, Barbara L.
    PSYCHO-ONCOLOGY, 2022, 31 (08) : 1399 - 1411
  • [27] "This Is the First Time I've Talked About This": Considerations When Conducting Qualitative Research Interviews with Adolescents and Young Adults with Cancer
    Davies, Jane P.
    McGill, Brittany C.
    Sansom-Daly, Ursula M.
    Wakefield, Claire E.
    Kelly, Daniel M.
    JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY, 2021, 10 (05) : 540 - 548
  • [28] Nonmetropolitan residence and other factors affecting clinical trial enrollment for adolescents and young adults with cancer in a US population-based study
    Mobley, Erin M.
    Charlton, Mary E.
    Ward, Marcia M.
    Lynch, Charles F.
    CANCER, 2019, 125 (13) : 2283 - 2290
  • [29] Systems-Level Change to Alleviate Barriers to Cancer Clinical Trial Access for Adolescents and Young Adults in Australia
    Ellis, Justine A.
    Malalasekera, Vajiranee S.
    Allan, Christie
    Choong, Peter F.
    Hansford, Jordan R.
    Hehir, Ryan
    Morello, Natasha
    O'Callaghan, Sally
    Orme, Lisa
    Phillipson, Nitya
    Rosenthal, Mark A.
    Sawyer, Susan
    Strong, Robyn
    Super, Leanne
    Watt, Angela
    Williams, Chris
    Woollett, Anne
    Robertson, Alexandra
    Lewin, Jeremy
    JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY, 2022, 11 (02) : 173 - 180
  • [30] Access to Clinical Trials for Adolescents and Young Adults With Cancer: A Meta-Research Analysis
    de Rojas, Teresa
    Neven, Anouk
    Terada, Mitsumi
    Garcia-Abos, Miriam
    Moreno, Lucas
    Gaspar, Nathalie
    Peron, Julien
    JNCI CANCER SPECTRUM, 2019, 3 (04)